<VariationArchive RecordType="classified" VariationID="450980" VariationName="NM_033380.3(COL4A5):c.2604del (p.Gly869fs)" VariationType="Deletion" Accession="VCV000450980" Version="4" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-08-06" DateCreated="2017-12-19" MostRecentSubmission="2022-12-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="446466" VariationID="450980">
      <GeneList>
        <Gene Symbol="COL4A5" FullName="collagen type IV alpha 5 chain" GeneID="1287" HGNC_ID="HGNC:2207" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="108439838" stop="108697545" display_start="108439838" display_stop="108697545" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="107683073" stop="107940774" display_start="107683073" display_stop="107940774" Strand="+" />
          </Location>
          <OMIM>303630</OMIM>
          <Haploinsufficiency last_evaluated="2020-09-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL4A5">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-09-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL4A5">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_033380.3(COL4A5):c.2604del (p.Gly869fs)</Name>
      <CanonicalSPDI>NC_000023.11:108620349:CCCC:CCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="108620350" stop="108620350" display_start="108620350" display_stop="108620350" variantLength="1" positionVCF="108620349" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="107863580" stop="107863580" display_start="107863580" display_stop="107863580" variantLength="1" positionVCF="107863579" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>G869fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.107863583del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.107863583del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.108620353del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.108620353del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011977.2" sequenceAccession="NG_011977" sequenceVersion="2" change="g.185430del">
            <Expression>NG_011977.2:g.185430del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000495.5" sequenceAccession="NM_000495" sequenceVersion="5" change="c.2604del">
            <Expression>NM_000495.5:c.2604del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000486.1" sequenceAccession="NP_000486" sequenceVersion="1" change="p.Gly869fs">
            <Expression>NP_000486.1:p.Gly869fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_033380.3" sequenceAccession="NM_033380" sequenceVersion="3" change="c.2604del" MANESelect="true">
            <Expression>NM_033380.3:c.2604del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_203699.1" sequenceAccession="NP_203699" sequenceVersion="1" change="p.Gly869fs">
            <Expression>NP_203699.1:p.Gly869fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_232" sequenceAccession="LRG_232">
            <Expression>LRG_232:g.185430del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_232t1" sequenceAccession="LRG_232t1">
            <Expression>LRG_232t1:c.2604del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_232p1" sequenceAccession="LRG_232p1" change="p.Gly869fs">
            <Expression>LRG_232p1:p.Gly869fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_232t2" sequenceAccession="LRG_232t2">
            <Expression>LRG_232t2:c.2604del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_232p2" sequenceAccession="LRG_232p2" change="p.Gly869fs">
            <Expression>LRG_232p2:p.Gly869fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658656866" DB="ClinGen" />
        <XRef Type="rs" ID="1556419850" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_033380.3(COL4A5):c.2604del (p.Gly869fs) AND not provided" Accession="RCV000519538" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-07-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_033380.3(COL4A5):c.2604del (p.Gly869fs) AND X-linked Alport syndrome" Accession="RCV002307528" Version="2">
        <ClassifiedConditionList TraitSetID="2968">
          <ClassifiedCondition DB="MedGen" ID="C4746986">X-linked Alport syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-29" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-03-29" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-12-19" MostRecentSubmission="2022-12-24">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <DescriptionHistory Dated="2022-11-18">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2968" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="220" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Alport syndrome 1, X-linked recessive</ElementValue>
                <XRef ID="Alport+Syndrome/335" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alport Syndrome and Thin Basement Membrane Nephropathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">X-linked Alport syndrome</ElementValue>
                <XRef ID="MONDO:0010520" DB="MONDO" />
                <XRef ID="88917" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NEPHROPATHY AND DEAFNESS, X-LINKED</ElementValue>
                <XRef Type="MIM" ID="301050" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ATS</ElementValue>
                <XRef ID="GTR000525320" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="301050" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XLAS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">ATS1</ElementValue>
                <XRef Type="MIM" ID="301050" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">COL4A5-Related Nephropathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5785" />
                <XRef ID="5785" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">In Alport syndrome (AS) a spectrum of phenotypes ranging from progressive renal disease with extrarenal abnormalities to isolated hematuria with a non-progressive or very slowly progressive course is observed. Approximately two thirds of AS is X-linked (XLAS); approximately 15% is autosomal recessive (ARAS), and approximately 20% is autosomal dominant (ADAS). In the absence of treatment, renal disease progresses from microscopic hematuria (microhematuria) to proteinuria, progressive renal insufficiency, and end-stage renal disease (ESRD) in all males with XLAS, and in all males and females with ARAS. Progressive sensorineural hearing loss (SNHL) is usually present by late childhood or early adolescence. Ocular findings include anterior lenticonus (which is virtually pathognomonic), maculopathy (whitish or yellowish flecks or granulations in the perimacular region), corneal endothelial vesicles (posterior polymorphous dystrophy), and recurrent corneal erosion. In individuals with ADAS, ESRD is frequently delayed until later adulthood, SNHL is relatively late in onset, and ocular involvement is rare.</Attribute>
                <XRef ID="NBK1207" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301386</ID>
                <ID Source="BookShelf">NBK1207</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2002">
                <ID Source="pmc">3110944</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">22166944</ID>
              </Citation>
              <XRef ID="63" DB="Orphanet" />
              <XRef ID="88917" DB="Orphanet" />
              <XRef ID="C4746986" DB="MedGen" />
              <XRef ID="MONDO:0010520" DB="MONDO" />
              <XRef Type="MIM" ID="301050" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1206029" SubmissionDate="2019-01-29" DateLastUpdated="2017-12-19" DateCreated="2017-12-19">
        <ClinVarSubmissionID localKey="GDX:1750683|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000619617" DateUpdated="2017-12-19" DateCreated="2017-12-19" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-07-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.2604delC variant in the COL4A5 gene causes a frameshift starting with codon Glycine 869, changes this amino acid to a Glutamic acid residue and creates a premature Stop codon at position 6 of the new reading frame, denoted p.Gly869GlufsX6. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). Although this variant has not been previously reported to our knowledge, we consider ti to be pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL4A5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_033380.1:c.2604delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5086145" SubmissionDate="2022-11-17" DateLastUpdated="2022-12-24" DateCreated="2022-11-19">
        <ClinVarSubmissionID localKey="2301165|OMIM:301050" />
        <ClinVarAccession Accession="SCV002603242" DateUpdated="2022-12-24" DateCreated="2022-11-19" Type="SCV" Version="2" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" OrgAbbreviation="MGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>NM_000495.4(COL4A5):c.2604delC(G869Efs*6) is expected to be pathogenic in the context of X-linked Alport syndrome. This variant is predicted to lead to an abnormal or absent protein product due to the creation of a premature termination codon in COL4A5, a gene where loss-of-function variants are known to be pathogenic. Please note: this variant was assessed in the context of healthy population screening.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Women's Health Autosomal Recessive and X-Linked Classification Criteria (2021)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/wpe7ty9o/myriad_women_s_health_autosomal_recessive_and_x-linked_classification_criteria_2021_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL4A5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="X" alternateAllele="T" referenceAllele="TC" start="107863579" stop="107863580" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">2301165</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="301050" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12292560</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1206029" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5086145" TraitType="Disease" MappingType="XRef" MappingValue="301050" MappingRef="OMIM">
        <MedGen CUI="C4746986" Name="X-linked Alport syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

